|European S3‐Guidelines on the systemic treatment of psoriasis vulgaris: Supported by the EDF/EADV/IPC|
D Pathirana, AD Ormerod, P Saiag, C Smith, PI Spuls, A Nast, J Barker, ...
Journal of the European Academy of Dermatology and Venereology 23, 1-70, 2009
|Prevalence of metabolic syndrome in patients with psoriasis: a hospital‐based case–control study|
P Gisondi, G Tessari, A Conti, S Piaserico, S Schianchi, A Peserico, ...
British Journal of Dermatology 157 (1), 68-73, 2007
|Regulatory activity of autocrine IL-10 on dendritic cell functions|
S Corinti, C Albanesi, A la Sala, S Pastore, G Girolomoni
The Journal of Immunology 166 (7), 4312-4318, 2001
|Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions|
BB Davidovici, N Sattar, PC Jörg, L Puig, P Emery, JN Barker, ...
Journal of Investigative Dermatology 130 (7), 1785-1796, 2010
|IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-γ …|
C Albanesi, A Cavani, G Girolomoni
The Journal of Immunology 162 (1), 494-502, 1999
|Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses|
P Fraticelli, M Sironi, G Bianchi, D D’Ambrosio, C Albanesi, ...
The Journal of clinical investigation 107 (9), 1173-1181, 2001
|The epidermal growth factor receptor system in skin repair and inflammation|
S Pastore, F Mascia, V Mariani, G Girolomoni
Journal of Investigative Dermatology 128 (6), 1365-1374, 2008
|Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-γ-and interleukin-4-induced activation of human keratinocytes|
C Albanesi, C Scarponi, A Cavani, M Federici, F Nasorri, G Girolomoni
Journal of Investigative Dermatology 115 (1), 81-87, 2000
|Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell–derived cytokines|
ML Giustizieri, F Mascia, A Frezzolini, O De Pitā, LM Chinni, A Giannetti, ...
Journal of Allergy and Clinical Immunology 107 (5), 871-877, 2001
|Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment|
C Albanesi, C Scarponi, S Pallotta, R Daniele, D Bosisio, S Madonna, ...
Journal of Experimental Medicine 206 (1), 249-258, 2009
|Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses|
A Cavani, F Nasorri, C Prezzi, S Sebastiani, C Albanesi, G Girolomoni
Journal of investigative dermatology 114 (2), 295-302, 2000
|Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey|
MG Lebwohl, H Bachelez, J Barker, G Girolomoni, A Kavanaugh, ...
Journal of the American Academy of Dermatology 70 (5), 871-881. e30, 2014
|Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity|
S Sebastiani, P Allavena, C Albanesi, F Nasorri, G Bianchi, C Traidl, ...
The Journal of Immunology 166 (2), 996-1002, 2001
|Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment|
A Wollenberg, S Reitamo, G Girolomoni, M Lahfa, T Ruzicka, E Healy, ...
Allergy 63 (7), 742-750, 2008
|Dendritic cells as a major source of macrophage‐derived chemokine/CCL22 in vitro and in vivo|
M Vulcano, C Albanesi, A Stoppacciaro, R Bagnati, G D'Amico, S Struyf, ...
European journal of immunology 31 (3), 812-822, 2001
|Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case–control study|
P Gisondi, I Tinazzi, G El-Dalati, M Gallo, D Biasi, LM Barbara, ...
Annals of the rheumatic diseases 67 (1), 26-30, 2008
|Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines|
PE Grimes, R Morris, E Avaniss-Aghajani, T Soriano, M Meraz, A Metzger
Journal of the American Academy of Dermatology 51 (1), 52-61, 2004
|Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator …|
P Gisondi, M Del Giglio, V Di Francesco, M Zamboni, G Girolomoni
The American journal of clinical nutrition 88 (5), 1242-1247, 2008
|Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation|
F Mascia, V Mariani, G Girolomoni, S Pastore
The American journal of pathology 163 (1), 303-312, 2003
|Alerting and tuning the immune response by extracellular nucleotides|
A La Sala, D Ferrari, F Di Virgilio, M Idzko, J Norgauer, G Girolomoni
Journal of leukocyte biology 73 (3), 339-343, 2003